Literature DB >> 18458271

National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease.

Otis W Brawley1, Llewellyn J Cornelius, Linda R Edwards, Vanessa Northington Gamble, Bettye L Green, Charles Inturrisi, Andra H James, Danielle Laraque, Magda Mendez, Carolyn J Montoya, Brad H Pollock, Lawrence Robinson, Aaron P Scholnik, Melissa Schori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18458271     DOI： 10.7326/0003-4819-148-12-200806170-00220

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  92 in total

1.  Effectiveness of antenatal screening for sickle cell trait: the impact on women's self-report of sickle cell trait status.

Authors:  J M Knight-Madden; M Reid; N Younger; D Francis; S McFarlane; R Wilks
Journal:  Pathog Glob Health       Date:  2012-03       Impact factor: 2.894

Review 2.  Fetal hemoglobin in sickle cell anemia.

Authors:  Idowu Akinsheye; Abdulrahman Alsultan; Nadia Solovieff; Duyen Ngo; Clinton T Baldwin; Paola Sebastiani; David H K Chui; Martin H Steinberg
Journal:  Blood       Date:  2011-04-13       Impact factor: 22.113

3.  Higher executive abilities following a blood transfusion in children and young adults with sickle cell disease.

Authors:  Anna M Hood; Allison A King; Melanie E Fields; Andria L Ford; Kristin P Guilliams; Monica L Hulbert; Jin-Moo Lee; Desiree A White
Journal:  Pediatr Blood Cancer       Date:  2019-07-03       Impact factor: 3.167

4.  Stwl modifies chromatin compaction and is required to maintain DNA integrity in the presence of perturbed DNA replication.

Authors:  Xia Yi; Hilda I de Vries; Katarzyna Siudeja; Anil Rana; Willy Lemstra; Jeanette F Brunsting; Rob M Kok; Yvo M Smulders; Matthias Schaefer; Freark Dijk; Yongfeng Shang; Bart J L Eggen; Harm H Kampinga; Ody C M Sibon
Journal:  Mol Biol Cell       Date:  2008-12-03       Impact factor: 4.138

Review 5.  Hemoglobin research and the origins of molecular medicine.

Authors:  Alan N Schechter
Journal:  Blood       Date:  2008-11-15       Impact factor: 22.113

6.  Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease.

Authors:  Amanda M Brandow; Julie A Panepinto
Journal:  Am J Hematol       Date:  2011-08-03       Impact factor: 10.047

Review 7.  Systematic and Meta-Analytic Review: Medication Adherence Among Pediatric Patients With Sickle Cell Disease.

Authors:  Kristin Loiselle; Jennifer L Lee; Lauren Szulczewski; Sarah Drake; Lori E Crosby; Ahna L H Pai
Journal:  J Pediatr Psychol       Date:  2015-09-18

Review 8.  Leg Ulcers in Sickle-Cell Disease: Treatment Update.

Authors:  Jean-Benoît Monfort; Patricia Senet
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-04-24       Impact factor: 4.730

9.  Predictors of Academic Achievement for School Age Children with Sickle Cell Disease.

Authors:  Kelsey E Smith; Chavis A Patterson; Margo M Szabo; Reem A Tarazi; Lamia P Barakat
Journal:  Adv Sch Ment Health Promot       Date:  2013-01-25

10.  Proteinuria in adults with sickle-cell disease: the role of hydroxycarbamide(hydroxyurea) as a protective agent.

Authors:  Geraldo B Silva Junior; Ana Patrícia F Vieira; Amanda X Couto Bem; Marília P Alves; Gdayllon C Meneses; Alice M C Martins; Sonia M H A Araújo; Alexandre V Libório; Elizabeth F Daher
Journal:  Int J Clin Pharm       Date:  2014-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.